KAUST has inaugurated the Computational Bioscience Research Center. The inauguration included a two-day symposium. Why it matters: This new center will likely boost computational biology research and applications in the region.
Michael Waterman, professor at USC, and Wei Wang, director at UCLA, gave keynote addresses at KAUST. Charlotte Hauser, KAUST professor of bioscience, also gave a keynote lecture. Peer Bork (EMBL) and Martin Noble spoke with Vladimir Bajic at the event. Why it matters: This indicates KAUST's ongoing engagement with international experts to advance research in computational biology.
KAUST's Computational Bioscience Research Center (CBRC) held a Research Conference on Big Data Analyses in Evolutionary Biology. The conference focused on the impact of large "omics" datasets on evolutionary biology, requiring big data approaches for analysis. Researchers discussed how computer science can contribute to biology and vice versa. Why it matters: Such interdisciplinary events at KAUST can foster innovation at the intersection of computational science and biology, advancing research in both fields.
KAUST Professor Takashi Gojobori has been elected as a Fellow of the International Society for Computational Biology (ISCB). ISCB is a scholarly society for computational biology and bioinformatics. Gojobori's research interests include comparative genomics and gene expression of neural cells, as well as the marine metagenomics of microorganisms. Why it matters: The recognition highlights KAUST's contributions to computational biology and bioinformatics and strengthens its position as a research hub in the region.
MBZUAI hosted a two-day workshop on "Big Model AI in Drug Design" starting February 20, 2023. The workshop featured presentations from researchers in public and private institutions working on AI and health. MBZUAI Adjunct Professor Eran Segal opened the workshop with a talk on the Human Phenotype Project. Why it matters: The event highlights the growing interest and activity in applying AI, particularly large models, to advance drug discovery and personalized medicine within the UAE's research ecosystem.